SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 11, 2003
CRYO-CELL International, Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
0-23386 |
22-3023093 | ||
| (State or other jurisdiction |
(Commission File Number) |
(IRS Employer | ||
| of incorporation) |
Identification No.) |
| 3165 McMullen Booth Road, Bldg. B, Clearwater, FL |
33761 | |
| (Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (727) 450-8000
Not applicable
(Former name or former address, if changed since last report)
Item 4. Changes to Registrant’s Certifying Accountant.
On March 11, 2003, upon the recommendation and approval of its Board of Directors and its Audit Committee, CRYO-CELL International, Inc. (the “Company”) dismissed Weinick Sanders Leventhal & Co., LLP (“Weinick Sanders”) as the Company’s independent auditors. On the same date, the Company engaged Ernst & Young LLP (“E&Y”) to serve as the Company’s independent auditors.
Weinick Sanders’ reports on the Company’s consolidated financial statements for each of the fiscal years ended November 30, 2002 and 2001 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. During the fiscal years ended November 30, 2002 and 2001 and subsequently through the date of its dismissal, there were no disagreements with Weinick Sanders on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to Weinick Sanders’ satisfaction, would have caused them to make reference to the subject matter in connection with their report on the Company’s consolidated financial statements for such years. The Company requested Weinick Sanders Leventhal & Co., LLP to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether Weinick Sanders Leventhal & Co., LLP agreed with certain statements. A copy of the letter from Weinick Sanders to the Securities and Exchange Commission dated March 14, 2003, stating whether or not it agrees with the above statements, is included as Exhibit 16.1 to this report.
During the fiscal years ended November 30, 2002 and 2001 and subsequently through the date of E&Y’s engagement, the Company did not consult E&Y with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, or any disagreement or event described under Item 304(a)(i)(iv) of Regulation S-B.
Item 7. Financial Statements and Exhibits
| (c) |
Exhibits. | |
| 16.1 |
Letter from Weinick Sanders Leventhal & Co., LLP dated March 14, 2003 | |
| 99.1 |
Press Release dated March 14, 2003 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CRYO-CELL INTERNATIONAL, INC. | ||||
| (Registrant) | ||||
| Date: March 17, 2003 |
By: |
/s/ Jill M. Taymans | ||
| Name: Jill M. Taymans | ||||
| Title: Vice President, Finance | ||||
3
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 16.1 |
Letter from Weinick Sanders Leventhal & Co., LLP dated March 14, 2003 | |
| 99.1 |
Press Release dated March 14, 2003 |
4